The Patent Finder

Galderma Holding S.A.

89 patents currently held · Updated Nov 16, 2026
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Nestlé Skin Health S.A. (to 2020)

10
Ending by 2030
Jun 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Nov 28 to 30, 2026 · next Nov 28
  • 1 fee due Dec 25, 2026
    The maintenance fee for Compound from the avermectin family for treating and/or preventing folliculitis (US 10,328,094) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
  • 3 fees due Jan 18 to 28, 2027 · next Jan 18
  • 2 fees due Feb 13 to 22, 2027 · next Feb 13
  • 1 fee due Mar 3, 2027
    The maintenance fee for Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis (US 10,398,720) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
  • 1 fee due Apr 10, 2027
    The maintenance fee for Carbohydrate Crosslinker (US 11,780,970) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 4 fees due Jul 9 to 12, 2027 · next Jul 9
  • 3 fees due Aug 11 to 13, 2027 · next Aug 11
  • 1 fee due Sep 26, 2027
    The maintenance fee for Method for Preparing Acylated Crosslinked Glycosaminoglycans (US 11,939,433) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
  • 1 fee due Oct 7, 2027
    The maintenance fee for BPO wash gel composition (US 10,610,594) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 3 of the patents on this record were granted since Aug 18, 2026
  • 5 terms have ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,795,425Production of bepromoline
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,859,603Method for solubilizing metronidazole
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,981,916Solubilizing of metronidazole
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,838,563Compounds, formulations, and methods for ameliorating telangiectasias
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,858,967Dermatological cream-gels containing avermectin compounds
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,778,909Method of Applying an Injectable Filler
In force
 · High confidence
In forceHigh confidence
US 8,049,007Preparation of amorolfine
In force
 · From the USPTO record
In forceFrom the USPTO record
US D727,727Sliding overcap for dispensing container
In force
 · From the USPTO record
In forceFrom the USPTO record
US D734,153Closure for a container
In force
 · From the USPTO record
In forceFrom the USPTO record
US D758,048Garment
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 89 patents shown.
Pro members see all 89.
Pro members: see all 89 patents
Also on record, not counted in the 89: 12 patents in force now held by others · 61 lapsed for an unpaid fee · 42 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

13 pending · 9 abandoned · 108 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited